Serina Therapeutics SER
NYSE SER
$2.77 +0.12 (+4.53%)
As of: Aug 21, 2026 · 3:34 PM EDT

Serina Therapeutics (SER) FCF Margin (QoQ) (2018 - 2024)

Serina Therapeutics (SER) FCF Margin (QoQ) (2018 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.09 Bn 131.23 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.66 Bn 77.66 Bn 3.93 Bn
3 Argenx Se 64.86 Bn 59.67 Bn 1.37 Bn
4 Moderna 58.07 Bn 52.93 Bn 52.00 Mn
5 BeOne Medicines 41.87 Bn 36.77 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.45 Bn 28.15 Bn 992.69 Mn
7 BioNTech SE 27.90 Bn 9.51 Bn 668.28 Mn
8 Insmed 27.40 Bn 26.24 Bn 358.27 Mn
9 Royalty Pharma 27.28 Bn 26.45 Bn -
10 Serina Therapeutics 45.39 Mn 22.36 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 5.40 Mn
Sep 30, 2024 -547,465.00
Jun 30, 2024 1.61 Mn
Mar 31, 2024 -3.18 Mn
Dec 31, 2023 394,303.00
Sep 30, 2023 840,148.00
Jun 30, 2023 -997,952.00
Mar 31, 2023 1.41 Mn
Dec 31, 2022 -277,917.00
Sep 30, 2022 81,667.00
Jun 30, 2022 1.82 Mn
Mar 31, 2022 -3.16 Mn
Dec 31, 2021 638,938.00
Sep 30, 2021 -265,338.00
Jun 30, 2021 -28,591.00
Mar 31, 2021 -338,951.00
Dec 31, 2020 148,713.00
Sep 30, 2020 254,889.00
Jun 30, 2020 -285,863.00
Mar 31, 2020 -183,070.00